Analytical Data
-
基因名
TARS
- Application
-
别名
ThrRS; PL-7; PL7; Threonine tRNA Ligase 1,Cytoplasmic
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P26639
-
表达区间
Met1~Ile300
-
分子量
40kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TARS (Threonyl-tRNA Synthetase) is a crucial enzyme in protein biosynthesis, catalyzing the attachment of threonine to its corresponding tRNA molecule. Its significance extends beyond this essential role; TARS is also implicated in various cellular processes and diseases. Recent studies have highlighted its involvement in mitochondrial function and the stress response, suggesting that TARS may play a role in conditions such as cancer and neurodegenerative disorders. The study of TARS is further motivated by its potential as a therapeutic target, especially given the rising interest in precision medicine and targeted therapies. With its dual functionality, understanding TARS and developing recombinant proteins that can modulate its activity could yield insights into its biochemical pathways and provide innovative strategies for disease intervention. The recombinant protein research surrounding TARS thus aims to elucidate its structural and functional mechanisms, paving the way for novel treatments that could manipulate its enzymatic activity for therapeutic benefits.
